NCT06361498

Brief Summary

The goal of this clinical trial is to compare using ultrasound imaging to look at the position of the gastrostomy tube (GT) against fluoroscopic imaging in pediatric patients who had a recent GT tube replacement. The main questions it aims to answer are:

  • If ultrasound is just as accurate as fluoroscopy to assess the GT position.
  • If ultrasound takes less time than fluoroscopy to assessing the GT position. Participants will be imaging using ultrasound to assess GT positioning before their standard of care fluoroscopic imaging.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
0mo left

Started Apr 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Apr 2024Jun 2026

First Submitted

Initial submission to the registry

March 22, 2024

Completed
21 days until next milestone

First Posted

Study publicly available on registry

April 12, 2024

Completed
18 days until next milestone

Study Start

First participant enrolled

April 30, 2024

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

June 18, 2025

Status Verified

June 1, 2025

Enrollment Period

2.1 years

First QC Date

March 22, 2024

Last Update Submit

June 13, 2025

Conditions

Keywords

gastrostomy tubeultrasoundfluoroscopy

Outcome Measures

Primary Outcomes (1)

  • Proportion of Ultrasound that Agree with Fluoroscopy with Respect to Identifying the GT Location

    Proportional accuracy of ultrasound in identifying the gastrostomy tube (GT) balloon location based on the readers' (radiologists) ability to use the ultrasound to locate the GT balloon in comparison with the gold standard (fluoroscopic tube injection).

    Upon completion of all study image data collection for all participants [approximately 1 year]

Secondary Outcomes (3)

  • Sensitivity of ultrasound (US) to determine the visualization of GT leakage

    Upon completion of all study image data collection for all participants [approximately 1 year]

  • Specificity of ultrasound (US) to determine the visualization of GT leakage

    Upon completion of all study image data collection for all participants [approximately 1 year]

  • Duration of ultrasound (US) to complete evaluation of GT position

    Upon completion of all study image data collection for all participants [approximately 1 year]

Study Arms (1)

Ultrasound Imaging

OTHER

This study consists of one group/ All participants will receive ultrasound imaging prior to the standard of care fluoroscopic imaging.

Device: Ultrasound Imaging

Interventions

Participant will receive ultrasound imaging to evaluate the replaced G-tube placement.

Ultrasound Imaging

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • An individual who presents with a dislodged GT and meets one of the following minor criteria:
  • Surgical GT placement less than 90 days from presentation
  • Traumatic GT dislodgement/removal
  • Recent stoma dilation
  • Clinician uncertainty about position of GT placement

You may not qualify if:

  • An individual \>18 years of age
  • Acutely ill patients defined as hemodynamically unstable defined as any child who has abnormal vital signs or disruption of vital functions (i.e. airway, breathing, circulation, mental function). Vital signs are based on patient age. Initial assessment of clinical patient stability will be provided by the ordering/referring provider.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27599, United States

RECRUITING

MeSH Terms

Interventions

Ultrasonography

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • William Pryor, MD

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hannah P Mignosa-Martin

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 22, 2024

First Posted

April 12, 2024

Study Start

April 30, 2024

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

June 18, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.

Shared Documents
STUDY PROTOCOL
Time Frame
9 to 36 months following publication.
Access Criteria
The investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.

Locations